Data / Form D filings / Strongbridge Biopharma plc
Strongbridge Biopharma plc: Form D filings
Strongbridge Biopharma plc, a pharmaceuticals company in Trevose, PA, filed 4 Form D notices with the SEC between 2015 and 2016. The latest, on December 30, 2016, reports $35 million sold of a $35 million offering to 23 investors.
Find out what Strongbridge Biopharma plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 900 NORTHBROOK DRIVE, Suite 200, Trevose, PA, 19053
- Phone
- (610) 254-9200
- Industry
- Pharmaceuticals
- Entity type
- Other (public limited company)
- Incorporated in
- Ireland
- Year incorporated
- 2015
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1634432
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2016 | New notice | $35,000,000 | $35,000,000 | $0 | 23 | Dec 22, 2016 | sec.gov |
| Sep 14, 2015 | New notice | $126,000,000 | $126,000,000 | $0 | 46 | Aug 28, 2015 | sec.gov |
| Jul 17, 2015 | New notice | $33,224,981 | $33,224,981 | $0 | 25 | Jun 29, 2015 | sec.gov |
| Feb 25, 2015 | New notice | $26,397,676 | $26,397,676 | $0 | 5 | Feb 10, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Garheng H. Kong | Director | |
| Stephen Brian Long | Executive Officer | |
| Jeffrey W. Sherman | Director | |
| Marten H. Steen | Director | |
| John H. Johnson | Director | |
| A. Brian Davis | Executive Officer | |
| Fredric Brian Cohen | Executive Officer | |
| Richard H. Kollender | Director | |
| Robert Brian Lutz | Executive Officer | |
| Hilde H. Steineger | Director | |
| Matthew Pauls | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Dec 26, 2016 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Strongbridge Biopharma plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.